Atra stock rating
ATRA Stock Rating and Data | Atara Biotherapeutics ... ATRA stock rating and analysis - Atara Biotherapeutics : a summary of key financial strength and profitability metrics. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Screeners Atara Biotherapeutics Inc (ATRA) Quote | Morningstar Mar 24, 2020 · Learn about ATRA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to …
Atara Biotherapeutics Stock Quote: ATRA Stock News, Quotes ...
Atara Biotherapeutics Inc's stock rating is based on fundamental analysis. Don't miss ATRA stock next rating changes Analyst Ratings for Atara Biotherapeutics (ATRA) Nov 08, 2019 · UPDATE: JPMorgan Downgrades Atara Biotherapeutics (ATRA) to Neutral Goldman Sachs Downgrades Atara Biotherapeutics (ATRA) to Sell Atara Biotherapeutics (ATRA) ATA188 Likely To Progress to Ph2 Weekly Research Analysts’ Ratings Changes for Atara ... 2/18/2020 – Atara Biotherapeutics had its “buy” rating reaffirmed by analysts at Canaccord Genuity. 1/25/2020 – Atara Biotherapeutics was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. ATRA stock opened at $9.35 on Wednesday. The firm’s 50-day moving average price is $11.66 and its two-hundred
Atara Biotherapeutics - ATRA - Stock Price & News | The ...
Atara Biotherapeutics Inc's stock rating is based on fundamental analysis. Don't miss ATRA stock next rating changes Analyst Ratings for Atara Biotherapeutics (ATRA) Nov 08, 2019 · UPDATE: JPMorgan Downgrades Atara Biotherapeutics (ATRA) to Neutral Goldman Sachs Downgrades Atara Biotherapeutics (ATRA) to Sell Atara Biotherapeutics (ATRA) ATA188 Likely To Progress to Ph2 Weekly Research Analysts’ Ratings Changes for Atara ... 2/18/2020 – Atara Biotherapeutics had its “buy” rating reaffirmed by analysts at Canaccord Genuity. 1/25/2020 – Atara Biotherapeutics was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. ATRA stock opened at $9.35 on Wednesday. The firm’s 50-day moving average price is $11.66 and its two-hundred ATRA Stock Price and Chart — NASDAQ:ATRA — TradingView View live ATARA BIOTHERAPEUTICS INC chart to track its stock's price action. Find market predictions, ATRA financials and market news.
View today's stock price, news and analysis for Atara Biotherapeutics Inc. (ATRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation
View the latest ATRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ATARA BIOTHERAPEUTICS, INC.. Here’s Why Atara Biotherapeutics, Inc. (ATRA) Is A Stock ... Mar 17, 2020 · Goldman repeated the rating from the previous report, marking ATRA under “Sell” rating, in the report published on September 27th, 2019. Additionally, ATRA shares got another “Hold” rating from Jefferies, setting a target price of $15 on the company’s shares, according to the report published in September 16th, 2019. Is Atara Biotherapeutics, Inc. (ATRA) Dependable ... Mar 02, 2020 · Goldman repeated the rating from the previous report, marking ATRA under “Sell” rating, in the report published on September 27th, 2019. Additionally, ATRA shares got another “Hold” rating from Jefferies, setting a target price of $15 on the company’s shares, according to the report published in September 16th, 2019.
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
View the latest ATRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of ATARA BIOTHERAPEUTICS, INC.. Here’s Why Atara Biotherapeutics, Inc. (ATRA) Is A Stock ... Mar 17, 2020 · Goldman repeated the rating from the previous report, marking ATRA under “Sell” rating, in the report published on September 27th, 2019. Additionally, ATRA shares got another “Hold” rating from Jefferies, setting a target price of $15 on the company’s shares, according to the report published in September 16th, 2019. Is Atara Biotherapeutics, Inc. (ATRA) Dependable ... Mar 02, 2020 · Goldman repeated the rating from the previous report, marking ATRA under “Sell” rating, in the report published on September 27th, 2019. Additionally, ATRA shares got another “Hold” rating from Jefferies, setting a target price of $15 on the company’s shares, according to the report published in September 16th, 2019.
Filter ATRA News Items All News Types Featured Stories Commentary Corp. News Cramer Debt Offering Downgrade Earnings Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Product News PT Lowered PT Raised Rating Reiterated (Bullish) Resumes Coverage (Bullish) Resumes Coverage (Neutral) Stock Offering Upgrade